Metabolism of nicotine to cotinine studied by a dual stable isotope method.
paper
Cited
Public
Unavailable
- Authors
- Benowitz, N L; Jacob, P
- Year
- 1994
- Journal
- Clinical pharmacology and therapeutics
- PMID
- 7955812
- DOI
- 10.1038/clpt.1994.169
OBJECTIVES: (1) To determine the disposition kinetics of nicotine and cotinine, including the fractional conversion of nicotine to cotinine, (2) to compare the disposition kinetics of deuterium-labeled and unlabeled cotinine, and (3) to develop a pharmacokinetically based method for estimating daily intake of nicotine from cigarette smoking. STUDY DESIGN: Twenty cigarette smokers received a combined infusion of deuterium-labeled nicotine (d2) and cotinine (d4). Six nonsmokers received a combined infusion of unlabeled cotinine, cotinine-d2 and cotinine-d4. Daily intake of nicotine was estimated with use of the plasma cotinine concentration during ad libitum smoking, clearance of labeled cotinine, and fractional conversion of nicotine to cotinine. RESULTS: The kinetics of labeled versus unlabeled cotinine and of cotinine in smokers versus nonsmokers were similar. On average, 72% of nicotine was converted to cotinine, with a range from 55% to 92%. Subjects with lower clearances of nicotine had lower fractional conversion of nicotine to cotinine, indicating that this is the most rapid of the proximate metabolic pathways for nicotine. The equation for estimating daily intake of nicotine from smoking was: Dnic (mg/24 hr) = K x (Plasma Cot) (ng/ml), where K averaged 0.08, with a range from 0.047 to 0.102. Individual variability in the clearance of cotinine (coefficient of variation, 27.5%) accounts for more of the variability in K than does variability in the fractional conversion of nicotine to cotinine (coefficient of variation, 12.3%). CONCLUSIONS: Our study provides quantitative data on individual variability in the extent of C-oxidation of nicotine to cotinine and a quantitative perspective on the use of plasma cotinine as an indicator of daily intake of nicotine from tobacco.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| ANA-12 restores testicular health by local neurochemicals in passive smoking/nicotine-exposed preclinical adult rats. | Rathore D et al. | β | 2026 | β |
| Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy. | Olawale ME et al. | β | 2026 | β |
| Suspect and non-targeted screening of exposure biomarkers in urine from Korean adults: Mining archived data for insights from the Korean National Environmental Health Survey 3rd cycle. | McGrath TJ et al. | β | 2026 | β |
| The Short Nicotine Dependence Index: A Simple and Versatile Self-Report Measure of Nicotine Dependence for General Populations. | Jackson SE et al. | β | 2026 | β |
| A diverse paper sensor for the rapid determination of nicotine and cotinine traces in air, vaping liquid, and human saliva. | Nihal S et al. | β | 2025 | β |
| Beyond self-reports: serum cotinine reveals sex-and age-related differences of smoking on all-cause and disease-specific mortality. | Jiang Q et al. | β | 2025 | β |
| Cigarette Smoke Exposure Impairs Fracture Healing in a Rat Model: Preferential Impairment of Endochondral Over Membranous Healing. | Reeves RA et al. | β | 2025 | β |
| Degradation of myosmine by a novel bacterial strain Sphingopyxis sp. J-6 and its degradation pathways. | Dang B et al. | β | 2025 | β |
| Diet inflammatory potential modifies the association between tobacco smoke exposure and lung function. | Li Y et al. | β | 2025 | β |
| Effects of Cigarette Smoking and 3-Day Smoking Abstinence on Translocator Protein 18βkDa Availability: A [<sup>18</sup>F]FEPPA Positron Emission Tomography Study. | Brody AL et al. | β | 2025 | β |
| Nicotine alters cellular activity and mRNA expression of patterns of Astrocytes. | Sewell L et al. | β | 2025 | β |
| Nicotine Dosimetry in Evaluating Electronic Cigarettes Compared to Cigarette Smoking: Implications for Tobacco Regulatory Science. | Benowitz NL et al. | β | 2025 | β |
| Nicotine promotes AngII-induced abdominal aortic aortopathies in female and male mice: role of sex hormones. | Ensor M et al. | β | 2025 | β |
| Paternal pre-conceptional smoking and semen quality in the adult son. | HΓ¦rvig KK et al. | β | 2025 | β |
| Physical activity, metabolites, and breast cancer associations. | Watts EL et al. | β | 2025 | β |
| Self-reported smoking, urine cotinine, and risk of incident hypertension: findings from the PREVEND prospective cohort study. | Kunutsor SK et al. | β | 2025 | β |
| Urinary cotinine cut-off concentrations in children under 5 years for assessing environmental tobacco smoke exposure: a systematic review and meta-analysis protocol. | Sayed Mohamed Zain SM et al. | β | 2025 | β |
| Active smoking in urban households: An association between urinary cotinine metabolite level and serum eGFR concentration. | Kunno J et al. | β | 2024 | β |
| Associations Between Childhood Trauma and Tobacco Use Outcomes in Adults after Overnight Abstinence. | Palmisano AN et al. | β | 2024 | β |
| Effect of cigarette smoke exposure and cessation on regional diffusion properties in rat intervertebral discs. | Kelley J et al. | β | 2024 | β |
| Secondhand Smoke Exposure Measured in Urinary Cotinine Levels and Severity of Pediatric Sleep Apnea. | Rubinstein BJ et al. | β | 2024 | β |
| Self-reported smoking, urine cotinine, and risk of type 2 diabetes: Findings from the PREVEND prospective cohort study. | Kunutsor SK et al. | β | 2024 | β |
| The Diverging Trend in Exposure to Environmental Tobacco Smoke Among US Children. | Twum F et al. | β | 2024 | β |
| The effects of tobacco 21 laws on smoking and vaping: Evidence from panel data and biomarkers. | Cotti C et al. | β | 2024 | β |
| Urine cotinine versus self-reported smoking and the risk of chronic kidney disease. | Kunutsor SK et al. | β | 2024 | β |
| Association between secondhand smoke and cancers in adults in the US population. | Zhang Z et al. | β | 2023 | β |
| A Transcriptomic Analysis of Smoking-Induced Gene Expression Alterations in Coronary Artery Disease Patients. | Merzah M et al. | β | 2023 | β |
| Biochemical validation of self-reported electronic nicotine delivery system and tobacco heaviness of use. | Addicott MA et al. | β | 2023 | β |
| Biomarker selection strategies based on compound stability in wastewater-based epidemiology. | Gao Z et al. | β | 2023 | β |
| Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine. | Kolli AR et al. | β | 2023 | β |
| Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers. | Perez-Paramo YX et al. | β | 2023 | β |
| Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD). | Nasrin S et al. | β | 2023 | β |
| Low level of urinary cotinine in pregnant women also matters: variability, exposure characteristics, and association with oxidative stress markers. | Zhang Y et al. | β | 2023 | β |
| <i>APOL1</i> Risk Variants Associate With the Prevalence of Stroke in African American Current and Past Smokers. | Rakic JM et al. | β | 2023 | β |
| Prenatal Exposure to Tobacco and Cannabis in Six Race/Ethnicity Groups during the First Three Years after Legalization of Cannabis for Recreational Use in California. | Kharrazi M et al. | β | 2023 | β |
| Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study. | Theilen LH et al. | β | 2023 | β |
| Smoke Exposure Reduces the Protective Effect of Physical Activity on Hypertension: Evidence from the National Health and Nutrition Examination Survey (NHANES) 2013-2018. | Li C et al. | β | 2023 | β |
| The Expression of the Alpha7 Nicotinic Acetylcholine Receptor and the Effect of Smoking in Curdlan-Administered SKG Mice. | Kim YE et al. | β | 2023 | β |
| The involvement of dopamine and D2 receptor-mediated transmission in effects of cotinine in male rats. | Tan X et al. | β | 2023 | β |
| Urinary arsenic and spontaneous pregnancy loss - a hypothesis-generating case-control investigation in western Romania. | Neamtiu IA et al. | β | 2023 | β |
| Ξ±7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling. | Oz M et al. | β | 2023 | β |
| A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette. | McEwan M et al. | β | 2022 | β |
| Association between Diet Quality and Adolescent Wheezing: Effect Modification by Environmental Tobacco Smoke Exposure. | Wang JG et al. | β | 2022 | β |
| Comparison of Carcinogen Biomarkers in Smokers of Menthol and Nonmenthol Cigarettes: The 2015-2016 National Health and Nutrition Examination Survey Special Sample. | Lin W et al. | β | 2022 | β |
| Electronic Cigarette Vaping Did Not Enhance the Neural Process of Working Memory for Regular Cigarette Smokers. | Kim DY et al. | β | 2022 | β |
| Fetal exposure to maternal cigarette smoking and male reproductive function in young adulthood. | HΓ¦rvig KK et al. | β | 2022 | β |
| Genetic differences in nicotine sensitivity and metabolism in C57BL/6J and NOD/ShiLtJ mouse strains. | Seemiller LR et al. | β | 2022 | β |
| Maternal nicotine metabolism moderates the impact of maternal cigarette smoking on infant birth weight: A Collaborative Perinatal Project investigation. | Stroud LR et al. | β | 2022 | β |
| Measurement of cigarette smoking: Comparisons of global self-report, returned cigarette filters, and ecological momentary assessment. | Ozga JE et al. | β | 2022 | β |
| Nicotine Exposure in the U.S. Population: Total Urinary Nicotine Biomarkers in NHANES 2015-2016. | Mazumder S et al. | β | 2022 | β |
| Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health Study. | Sosnoff CS et al. | β | 2022 | β |
| The association between tobacco smoke exposure and vitamin D levels among US general population, 2001-2014: temporal variation and inequalities in population susceptibility. | Yuan L et al. | β | 2022 | β |
| The involvement of mesolimbic dopamine system in cotinine self-administration in rats. | Tan X et al. | β | 2022 | β |
| Characterizing nicotine exposure among a community sample of non-daily smokers in the United States. | Hobkirk AL et al. | β | 2021 | β |
| Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. | Tan X et al. | β | 2021 | β |
| Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance. | Liakoni E et al. | β | 2021 | β |
| Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study. | Spinella TC et al. | β | 2021 | β |
| <i>NAT1</i> genetic variation increases asthma risk in children with secondhand smoke exposure. | Brooks CC et al. | β | 2021 | β |
| New Biomarkers Based on Smoking-Related Phenotypes for Smoking Cessation Outcomes of Nicotine Replacement Therapy: A Prospective Study. | Nikkholgh A et al. | β | 2021 | β |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | β | 2021 | β |
| Recent Developments in the Determination of Biomarkers of Tobacco Smoke Exposure in Biological Specimens: A Review. | Marques H et al. | β | 2021 | β |
| Self-Administration of Cotinine in Wistar Rats: Comparisons to Nicotine. | Ding ZM et al. | β | 2021 | β |
| The risk of colorectal neoplasm in ex- and never-smokers according to urinary cotinine level. | Roh SJ et al. | β | 2021 | β |
| Urinary Cotinine and Nicotine Dependence Levels in Regular Male Electronic Cigarette Users. | Pamungkasningsih SW et al. | β | 2021 | β |
| Vaping and lung cancer - A review of current data and recommendations. | Bracken-Clarke D et al. | β | 2021 | β |
| Anabasine-based measurement of cigarette consumption using wastewater analysis. | Bade R et al. | β | 2020 | β |
| Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies. | Kovar L et al. | β | 2020 | β |
| Do hair follicles operate as primitive, multifocal kidney-like excretory (mini-) organs? | CarrΓ© JL et al. | β | 2020 | β |
| Impact of nicotine-induced green tobacco sickness on DNA damage and the relation with symptoms and alterations of redox status in tobacco farmers. | Alves J et al. | β | 2020 | β |
| Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde. | Espiritu MJ et al. | β | 2020 | β |
| More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder. | Moerke MJ et al. | β | 2020 | β |
| Nicotine in Senescence and Atherosclerosis. | Centner AM et al. | β | 2020 | β |
| Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007-2012. | Fu Z et al. | β | 2020 | β |
| Pilot Randomized Controlled Trial of a Digital Storytelling Intervention for Smoking Cessation in Women Living With HIV. | Kim SS et al. | β | 2020 | β |
| Prediction of Smoking Abstinence in Women Living With Human Immunodeficiency Virus Infection. | Kim SS et al. | β | 2020 | β |
| The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in Mice. | Chen YC et al. | β | 2020 | β |
| Aldehyde oxidase and its role as a drug metabolizing enzyme. | Dalvie D et al. | β | 2019 | β |
| Assessment of cotinine in urine and saliva of smokers, passive smokers, and nonsmokers: Method validation using liquid chromatography and mass spectrometry. | Sharma P et al. | β | 2019 | β |
| Assessment of the accuracy of salivary cotinine readings from NicAlert strips against a liquid chromatography tandem mass spectrometry assay in self-reported non-smokers who passed carbon monoxide but failed NicAlert validation. | Etter JF | β | 2019 | β |
| Association between cigarette smoking and diabetes mellitus using two different smoking stratifications in 145 040 Korean individuals: Self-reported questionnaire and urine cotinine concentrations. | Kim JH et al. | β | 2019 | β |
| Association Between Cotinine-verified Smoking Status and Risk of Colorectal Neoplasia. | Kim NH et al. | β | 2019 | β |
| Clinical Practice Guidelines for the management of conduct disorder. | Sagar R et al. | β | 2019 | β |
| Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population. | Glatard A et al. | β | 2019 | β |
| Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients. | Imabayashi T et al. | β | 2019 | β |
| Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum. | Arger CA et al. | β | 2019 | β |
| Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers. | Liakoni E et al. | β | 2019 | β |
| Technology-based contingency management and e-cigarettes during the initial weeks of a smoking quit attempt. | Martner SG et al. | β | 2019 | β |
| The neurobiology of addiction. | Uhl GR et al. | β | 2019 | β |
| A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine. | Taghavi T et al. | β | 2018 | β |
| A randomized controlled pilot trial of a smoking cessation intervention for US women living with HIV: telephone-based video call vs voice call. | Kim SS et al. | β | 2018 | β |
| Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease. | Kim NH et al. | β | 2018 | β |
| Biomarkers of Exposure to Secondhand and Thirdhand Tobacco Smoke: Recent Advances and Future Perspectives. | Torres S et al. | β | 2018 | β |
| Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum. | Taghavi T et al. | β | 2018 | β |
| Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). | Larose TL et al. | β | 2018 | β |
| Commentary on Taghavi et al. (2018): Accurate measurement of tobacco smoke exposure and smoking behaviour matters. | Coleman T | β | 2018 | β |
| Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health. | Tsai MS et al. | β | 2018 | β |
| E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. | Lee HW et al. | β | 2018 | β |
| Green Tobacco Sickness Among Tobacco Harvesters in a Korean Village. | Park SJ et al. | β | 2018 | β |
| Isolation and characterization of the cotinine-degrading bacterium Nocardioides sp. Strain JQ2195. | Qiu J et al. | β | 2018 | β |
| Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways. | Taghavi T et al. | β | 2018 | β |
| Lung cancer health disparities. | Ryan BM | β | 2018 | β |
| Molecular basis of vascular damage caused by cigarette smoke exposure and a new approach to the treatment: Alpha-linolenic acid. | Kaplan HM et al. | β | 2018 | β |
| Nicotine dependence, internalizing symptoms, mood variability and daily tobacco use among young adult smokers. | Bares CB et al. | β | 2018 | β |
| Nicotine deprivation increases pain intensity, neurogenic inflammation, and mechanical hyperalgesia among daily tobacco smokers. | Ditre JW et al. | β | 2018 | β |
| Relationships Between Smoking Behaviors and Cotinine Levels Among Two American Indian Populations With Distinct Smoking Patterns. | Tanner JA et al. | β | 2018 | β |
| Self-Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End-Stage Disease) Prospective Cohort Study. | Kunutsor SK et al. | β | 2018 | β |
| The metabolic fate of dietary nicotine in the cabbage looper, Trichoplusia ni (HΓΌbner). | Saremba BM et al. | β | 2018 | β |
| Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. | Bozinoff N et al. | β | 2018 | β |
| Urine Cotinine level with smoking history predicts a risk of coronary artery calcification. | Yu HJ et al. | β | 2018 | β |
| Biomarkers of exposure to new and emerging tobacco delivery products. | Schick SF et al. | β | 2017 | β |
| Comparative assessment of salivary cotinine level and psychological dependence among tobacco users. | Patel VD et al. | β | 2017 | β |
| Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma. | Mamsen LS et al. | β | 2017 | β |
| Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. | LΓ³pez-Flores LA et al. | β | 2017 | β |
| Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [<sup>11</sup>C]DAA1106 Positron Emission Tomography Study. | Brody AL et al. | β | 2017 | β |
| Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans. | Taghavi T et al. | β | 2017 | β |
| Efficacy of vitamins E and C for reversing the cytotoxic effects of nicotine and cotinine. | Torshabi M et al. | β | 2017 | β |
| Ethnic differences in current smoking and former smoking in the Netherlands and the contribution of socioeconomic factors: a cross-sectional analysis of the HELIUS study. | Brathwaite R et al. | β | 2017 | β |
| Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007-2012. | Saxena K et al. | β | 2017 | β |
| Heterogeneity in Smokers' Responses to Tobacco Control Policies. | Nesson E | β | 2017 | β |
| Increased HPA Axis Activity and Serum Tryptophan in Naswar (Dipping Tobacco) Users: A Case-Control Study. | Sajid F et al. | β | 2017 | β |
| Lower urinary cotinine level is associated with a trend toward more myopic refractive errors in Korean adolescents. | Nam GE et al. | β | 2017 | β |
| Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives. | Gracia-Lor E et al. | β | 2017 | β |
| Non-smoking pregnant women and their fetuses are exposed to environmental tobacco smoke as a result of living in multiunit housing. | Orazine CI et al. | β | 2017 | β |
| Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch. | Linakis MW et al. | β | 2017 | β |
| Tobacco use disorder and treatment: new challenges and opportunities. | Ziedonis D et al. | β | 2017 | β |
| Variation in CYP2A6 Activity and Personalized Medicine. | Tanner JA et al. | β | 2017 | β |
| Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer. | Tanner JA et al. | β | 2017 | β |
| Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting. | Fogli S et al. | β | 2016 | β |
| A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings. | Kim SS et al. | β | 2016 | β |
| Direct screening of tobacco indicators in urine and saliva by Atmospheric Pressure Solid Analysis Probe coupled to quadrupole-time of flight mass spectrometry (ASAP-MS-Q-TOF-). | Carrizo D et al. | β | 2016 | β |
| Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity. | Benowitz NL et al. | β | 2016 | β |
| Does a Race-Gender-Age Crossover Effect Exist in Current Cigarette Smoking Between Non-Hispanic Blacks and Non-Hispanic Whites? United States, 2001-2013. | Caraballo RS et al. | β | 2016 | β |
| Effects of Large Financial Incentives forΒ Long-Term Smoking Cessation: AΒ Randomized Trial. | Etter JF et al. | β | 2016 | β |
| Estimation of Saliva Cotinine Cut-Off Points for Active and Passive Smoking during Pregnancy-Polish Mother and Child Cohort (REPRO_PL). | Polanska K et al. | β | 2016 | β |
| Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. | Schaller JP et al. | β | 2016 | β |
| Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. | Chan J et al. | β | 2016 | β |
| Medical swab touch spray-mass spectrometry for newborn screening of nicotine and cotinine in meconium. | Yang BC et al. | β | 2016 | β |
| Metabolomics evaluation of the impact of smokeless tobacco exposure on the oral bacterium Capnocytophaga sputigena. | Sun J et al. | β | 2016 | β |
| Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers. | Fagan P et al. | β | 2016 | β |
| Novel nicotine analogues with potential anti-mycobacterial activity. | Gandhi PT et al. | β | 2016 | β |
| Overview of Cotinine Cutoff Values for Smoking Status Classification. | Kim S | β | 2016 | β |
| Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. | Ross KC et al. | β | 2016 | β |
| Simultaneous, rapid, and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine by on-line solid-phase extraction LC-MS/MS: correlation with tobacco exposure biomarkers NNAL. | Chen CY et al. | β | 2016 | β |
| The Influence of Puff Characteristics, Nicotine Dependence, and Rate of Nicotine Metabolism on Daily Nicotine Exposure in African American Smokers. | Ross KC et al. | β | 2016 | β |
| What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. | Le Foll B | β | 2016 | β |
| Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. | Benowitz NL et al. | β | 2015 | β |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | β | 2015 | β |
| Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer. | Fagan P et al. | β | 2015 | β |
| Cotinine as a marker for risk prediction in the Ludwigshafen Risk and Cardiovascular Health Study. | Delgado G et al. | β | 2015 | β |
| Effect of experimental kidney disease on the functional expression of hepatic reductases. | Alshogran OY et al. | β | 2015 | β |
| Involvement of the H+/organic cation antiporter in nicotine transport in rat liver. | Tega Y et al. | β | 2015 | β |
| N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort. | LeMasters GK et al. | β | 2015 | β |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | β | 2015 | β |
| The Collection and Analysis of Carbon Monoxide Levels as an Indirect Measure of Smoke Exposure in Pregnant Adolescents at a Multidisciplinary Teen Obstetrics Clinic. | Lopez AS et al. | β | 2015 | β |
| The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. | Patel YM et al. | β | 2015 | β |
| Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease. | Barreto GE et al. | β | 2014 | β |
| Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. | Bolleddula J et al. | β | 2014 | β |
| Children's exposure to secondhand and thirdhand smoke carcinogens and toxicants in homes of hookah smokers. | Kassem NO et al. | β | 2014 | β |
| Enhanced nicotine metabolism in HIV-1-positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using a simple and sensitive electrospray ionization liquid chromatography-tandem mass spectrometry technique. | Earla R et al. | β | 2014 | β |
| Fatal intravenous injection of electronic nicotine delivery system refilling solution. | Thornton SL et al. | β | 2014 | β |
| Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis. | Vandenbergh DJ et al. | β | 2014 | β |
| High-throughput determination of nicotine in plasma by ultrasonication enhanced hollow fiber liquid-phase microextraction prior to gas chromatography. | Liu X et al. | β | 2014 | β |
| Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. | Berlin I et al. | β | 2014 | β |
| Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolites. | Piller M et al. | β | 2014 | β |
| Utility and cutoff value of hair nicotine as a biomarker of long-term tobacco smoke exposure, compared to salivary cotinine. | Kim S et al. | β | 2014 | β |
| Variation in nicotine intake among U.S. cigarette smokers during the past 25 years: evidence from NHANES surveys. | Jarvis MJ et al. | β | 2014 | β |
| A simple, fast, and sensitive method for the measurement of serum nicotine, cotinine, and nornicotine by LC-MS/MS. | Yuan C et al. | β | 2013 | β |
| Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour. | Ebner N et al. | β | 2013 | β |
| Consideration of species differences in developing novel molecules as cognition enhancers. | Young JW et al. | β | 2013 | β |
| CYP2A6 genotype but not age determines cotinine half-life in infants and children. | Dempsey DA et al. | β | 2013 | β |
| Detection of tobacco-related biomarkers in urine samples by surface-enhanced Raman spectroscopy coupled with thin-layer chromatography. | Huang R et al. | β | 2013 | β |
| Effects of nicotine, its metabolites and tobacco extracts on human platelet function in vitro. | Ljungberg LU et al. | β | 2013 | β |
| Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. | Stragierowicz J et al. | β | 2013 | β |
| Nicotine metabolism and addiction among adolescent smokers. | Rubinstein ML et al. | β | 2013 | β |
| Nicotinic receptors in neurodegeneration. | Posadas I et al. | β | 2013 | β |
| NNAL exposure by race and menthol cigarette use among U.S. smokers. | Rostron B | β | 2013 | β |
| Novel insights on the effect of nicotine in a murine colitis model. | AlSharari SD et al. | β | 2013 | β |
| Optimum cutoff value of urinary cotinine distinguishing South Korean adult smokers from nonsmokers using data from the KNHANES (2008-2010). | Kim S et al. | β | 2013 | β |
| Simultaneous serum nicotine, cotinine, and trans-3'-hydroxycotinine quantitation with minimal sample volume for tobacco exposure status of solid organ transplant patients. | Shu I et al. | β | 2013 | β |
| The effectiveness of breath carbon monoxide analyzer in screening for environmental tobacco smoke exposure in Saudi pregnant women. | Alzeidan RA et al. | β | 2013 | β |
| The Twin Research Registry at SRI International. | Krasnow RE et al. | β | 2013 | β |
| Tobacco smoke and pregnancy: segmental analysis of nicotine in maternal hair. | BrajenoviΔ N et al. | β | 2013 | β |
| Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. | Zhu AZ et al. | β | 2013 | β |
| Workplace exposure to secondhand smoke among non-smoking hospitality employees. | Lawhorn NA et al. | β | 2013 | β |
| CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. | Binnington MJ et al. | β | 2012 | β |
| Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys. | Ferguson CS et al. | β | 2012 | β |
| Do initial responses to drugs predict future use or abuse? | de Wit H et al. | β | 2012 | β |
| Pathobiologic mechanisms of chronic obstructive pulmonary disease. | Tam A et al. | β | 2012 | β |
| Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. | Hurley LL et al. | β | 2012 | β |
| Simultaneous determination of nicotine and PAH metabolites in human hair specimen: a potential methodology to assess tobacco smoke contribution in PAH exposure. | Appenzeller BM et al. | β | 2012 | β |
| Smoking and the skin. | Ortiz A et al. | β | 2012 | β |
| Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. | Portugal GS et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. | Terry AV et al. | β | 2012 | β |
| Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities. | Berlin I et al. | β | 2011 | β |
| A new look at quantifying tobacco exposure during pregnancy using fuzzy clustering. | Fang H et al. | β | 2011 | β |
| Application of molecularly imprinted polymer solid-phase extraction for salivary cotinine. | Vitor RV et al. | β | 2011 | β |
| GSTM1 modifies the effect of maternal exposure to environmental tobacco smoke on neonatal primitive reflexes. | Hsieh CJ et al. | β | 2011 | β |
| Impact of cigarette smoking on volatile organic compound (VOC) blood levels in the U.S. population: NHANES 2003-2004. | Chambers DM et al. | β | 2011 | β |
| Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career. | Terry AV et al. | β | 2011 | β |
| Oral fluid nicotine markers to assess smoking status and recency of use. | Scheidweiler KB et al. | β | 2011 | β |
| Prenatal tobacco exposure is related to neurobehavioral modifications in infants of adolescent mothers. | Barros MC et al. | β | 2011 | β |
| Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. | West O et al. | β | 2011 | β |
| A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. | Miller EI et al. | β | 2010 | β |
| Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. | Hukkanen J et al. | β | 2010 | β |
| Environmental and biological monitoring of exposures to PAHs and ETS in the general population. | Aquilina NJ et al. | β | 2010 | β |
| Estimating tar and nicotine exposure: human smoking versus machine generated smoke yields. | St Charles FK et al. | β | 2010 | β |
| Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. | Chen G et al. | β | 2010 | β |
| Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. | Al Koudsi N et al. | β | 2010 | β |
| Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. | Al Koudsi N et al. | β | 2010 | β |
| Internet suicide guidelines: report of a life-threatening poisoning using tobacco extract. | Schneider S et al. | β | 2010 | β |
| Intrauterine tobacco exposure may alter auditory brainstem responses in newborns. | Peck JD et al. | β | 2010 | β |
| Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions. | Paulson JR et al. | β | 2010 | β |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Reliability of self-reported nicotine use as determined by serum cotinine levels in patients referred for liver transplantation. | Bright RP et al. | β | 2010 | β |
| A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo. | Al Koudsi N et al. | β | 2009 | β |
| Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. | Ho MK et al. | β | 2009 | β |
| Calibrating self-reported measures of maternal smoking in pregnancy via bioassays using a Monte Carlo approach. | Dukic VM et al. | β | 2009 | β |
| D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. | Santa Ana EJ et al. | β | 2009 | β |
| Does longstanding nicotine exposure impair bone healing and osseointegration? An experimental study in rabbits. | Gotfredsen K et al. | β | 2009 | β |
| Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. | Florescu A et al. | β | 2009 | β |
| Molecular genetics of nicotine metabolism. | Mwenifumbo JC et al. | β | 2009 | β |
| Nicotine chemistry, metabolism, kinetics and biomarkers. | Benowitz NL et al. | β | 2009 | β |
| Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. | Ray R et al. | β | 2009 | β |
| Polymorphisms in metabolic genes CYP1A1 and GSTM1 and changes in maternal smoking during pregnancy. | Chen X et al. | β | 2009 | β |
| Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. | Amiaz R et al. | β | 2009 | β |
| Sensitivity of young rats to nicotine exposure: Physiological and biochemical parameters. | JΓ³sΓͺ AS et al. | β | 2009 | β |
| Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. | Shakleya DM et al. | β | 2009 | β |
| Utility and relationships of biomarkers of smoking in African-American light smokers. | Ho MK et al. | β | 2009 | β |
| A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. | Ho MK et al. | β | 2008 | β |
| Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. | Riveles K et al. | β | 2008 | β |
| Comparison of CO breath testing and women's self-reporting of smoking behaviour for identifying smoking during pregnancy | Usmani Z et al. | β | 2008 | β |
| Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum. | O'Leary K et al. | β | 2008 | β |
| CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age. | Hsieh CJ et al. | β | 2008 | β |
| Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. | Myers CS et al. | β | 2008 | β |
| Effect of gestational smoke exposure on atopic dermatitis in the offspring. | Wang IJ et al. | β | 2008 | β |
| Evaluating screening performances of the Fagerstrom tolerance questionnaire, the Fagerstrom test for nicotine dependence and the heavy smoking index among Taiwanese male smokers. | Huang CL et al. | β | 2008 | β |
| Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. | Stepanov I et al. | β | 2008 | β |
| Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. | Mwenifumbo JC et al. | β | 2008 | β |
| Measuring nicotine intake among highly-dependent adolescent smokers: comparability of saliva and plasma cotinine concentrations. | Parzynski CS et al. | β | 2008 | β |
| Nicotine and cotinine in infants dying from sudden infant death syndrome. | Bajanowski T et al. | β | 2008 | β |
| Smoking characteristics and saliva cotinine levels in Taiwanese smokers: gender differences. | Huang CL et al. | β | 2008 | β |
| Use of nicotine replacement therapy among never smokers in the 1999-2006 National Health and Nutrition Examination Surveys. | Gerlach KK et al. | β | 2008 | β |
| A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups. | Fernander AF et al. | β | 2007 | β |
| Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. | Vesper HW et al. | β | 2007 | β |
| Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. | Ring HZ et al. | β | 2007 | β |
| Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. | Mwenifumbo JC et al. | β | 2007 | β |
| Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism. | Chen G et al. | β | 2007 | β |
| Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. | Mwenifumbo JC et al. | β | 2007 | β |
| Non-nicotinic therapies for smoking cessation. | Siu EC et al. | β | 2007 | β |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | β | 2007 | β |
| Population pharmacokinetics of nicotine and its metabolites I. Model development. | Levi M et al. | β | 2007 | β |
| Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis. | Florescu A et al. | β | 2007 | β |
| Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine. | Stepanov I et al. | β | 2007 | β |
| Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. | Feng S et al. | β | 2007 | β |
| The role of CYP2A6 in the emergence of nicotine dependence in adolescents. | Audrain-McGovern J et al. | β | 2007 | β |
| Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. | O'Connor RJ et al. | β | 2006 | β |
| Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. | Al Koudsi N et al. | β | 2006 | β |
| Correlating atmospheric and biological markers in studies of secondhand tobacco smoke exposure and dose in children and adults. | Repace J et al. | β | 2006 | β |
| CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. | Kubota T et al. | β | 2006 | β |
| Human flavin-containing monooxygenases. | Cashman JR et al. | β | 2006 | β |
| Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. | Malaiyandi V et al. | β | 2006 | β |
| Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. | Stepanov I et al. | β | 2006 | β |
| Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers. | Faessel HM et al. | β | 2006 | β |
| Salivary cotinine concentration versus self-reported cigarette smoking: Three patterns of inconsistency in adolescence. | Kandel DB et al. | β | 2006 | β |
| Significance of ammonium compounds on nicotine exposure to cigarette smokers. | Willems EW et al. | β | 2006 | β |
| Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. | Rasmusson AM et al. | β | 2006 | β |
| Tailoring nicotine replacement therapy: rationale and potential approaches. | McClure JB et al. | β | 2006 | β |
| The epidemiology of tobacco use and dependence. | Hudmon KS et al. | β | 2006 | β |
| Effect of nicotine on lung S-adenosylmethionine and development of Pneumocystis pneumonia. | Shivji M et al. | β | 2005 | β |
| Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method. | Mwenifumbo JC et al. | β | 2005 | β |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | β | 2005 | β |
| Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. | Malaiyandi V et al. | β | 2005 | β |
| Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. | Hukkanen J et al. | β | 2005 | β |
| Metabolism and disposition kinetics of nicotine. | Hukkanen J et al. | β | 2005 | β |
| Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in Wistar rats. | Kalpana C et al. | β | 2005 | β |
| Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. | Swan GE et al. | β | 2005 | β |
| Porcine CYP2A polymorphisms and activity. | Skaanild MT et al. | β | 2005 | β |
| The impact of nicotine on osseointegration. An experimental study in the femur and tibia of rabbits. | Balatsouka D et al. | β | 2005 | β |
| A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. | Murphy SE et al. | β | 2004 | β |
| Assessing nicotine metabolism in pregnancy--a novel approach using hair analysis. | Klein J et al. | β | 2004 | β |
| Cigarette smoking: Evidence to guide measurement. | Stevens KR et al. | β | 2004 | β |
| Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. | Schoedel KA et al. | β | 2004 | β |
| Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. | O'Loughlin J et al. | β | 2004 | β |
| Genetics of tobacco use. | Maserejian NN et al. | β | 2004 | β |
| Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). | Dorne JL et al. | β | 2004 | β |
| Mentholated cigarette smoking inhibits nicotine metabolism. | Benowitz NL et al. | β | 2004 | β |
| Metabolism and biochemical effects of nicotine for primary care providers. | Metz CN et al. | β | 2004 | β |
| Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. | Ingram JR et al. | β | 2004 | β |
| Postnatal expression of cytochrome P450 1A1, 2A3, and 2B1 mRNA in neonatal rat lung: influence of maternal nicotine exposure. | Gamieldien K et al. | β | 2004 | β |
| Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. | Chan D et al. | β | 2004 | β |
| [Update on the treatment of tobacco dependence]. | Sampablo Lauro I et al. | β | 2004 | β |
| [Usefulness of biological markers in evaluation of smoking]. | Larramendy C et al. | β | 2004 | β |
| Correction of urine cotinine concentrations for creatinine excretion: is it useful? | Jatlow P et al. | β | 2003 | β |
| Environmental tobacco smoke in the workplace: markers of exposure, polymorphic enzymes and implications for disease state. | Collier AC et al. | β | 2003 | β |
| Genetic influences on smoking behavior and nicotine dependence: a review. | Yoshimasu K et al. | β | 2003 | β |
| N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. | Kuehl GE et al. | β | 2003 | β |
| Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. | Tricker AR | β | 2003 | β |
| Smoking during pregnancy and newborn neurobehavior. | Law KL et al. | β | 2003 | β |
| The pharmacology of cocaethylene in humans following cocaine and ethanol administration. | Harris DS et al. | β | 2003 | β |
| Tobacco use and dependence. | Sohn M et al. | β | 2003 | β |
| Accelerated metabolism of nicotine and cotinine in pregnant smokers. | Dempsey D et al. | β | 2002 | β |
| CYP2A6 genetic variation and potential consequences. | Xu C et al. | β | 2002 | β |
| Estimation of environmental tobacco smoke exposure during pregnancy using a single question on household smokers versus serum cotinine. | Kaufman FL et al. | β | 2002 | β |
| Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. | Tyndale RF et al. | β | 2002 | β |
| Hair as a biomarker for exposure to tobacco smoke. | Al-Delaimy WK | β | 2002 | β |
| Molecular orbital calculations and nicotine metabolism: a rationale for experimentally observed metabolite ratios. | Lewis DF et al. | β | 2002 | β |
| Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. | Abbruscato TJ et al. | β | 2002 | β |
| Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. | Moyer TP et al. | β | 2002 | β |
| Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. | Benowitz NL et al. | β | 2002 | β |
| Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. | de Leon J et al. | β | 2002 | β |
| A controlled trial of an environmental tobacco smoke reduction intervention in low-income children with asthma. | Wilson SR et al. | β | 2001 | β |
| Assessment of nicotine uptake from cigarette smoke: comparison of a colorimetric test strip (NicCheck Iβ’) and gas chromatography/mass selective detector. | Thomas Karnes H et al. | β | 2001 | β |
| Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. | Jarvis MJ et al. | β | 2001 | β |
| Systemic nicotine exposure in tobacco harvesters. | D'Alessandro A et al. | β | 2001 | β |
| Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. | Benowitz NL et al. | β | 2001 | β |
| Clinical pharmacology of oral cotinine. | Zevin S et al. | β | 2000 | β |
| Short-term treatment with transdermal nicotine affects the function of canine saphenous veins. | Clouse WD et al. | β | 2000 | β |
| Urinary cotinine levels of smokeless tobacco (MaraΕ powder) users. | Cok I et al. | β | 2000 | β |
| Biomarkers of environmental tobacco smoke exposure. | Benowitz NL | β | 1999 | β |
| Cigarette smoking. | Bergen AW et al. | β | 1999 | β |
| Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. | Siegmund B et al. | β | 1999 | β |
| Implications of genetic epidemiology for the prevention of tobacco use. | Swan GE | β | 1999 | β |
| Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. | Jacob P et al. | β | 1999 | β |
| The adverse health effects of tobacco and tobacco-related products. | Mitchell BE et al. | β | 1999 | β |
| Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. | Bentley MC et al. | β | 1999 | β |
| Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. | Lawson GM et al. | β | 1998 | β |
| Clinical status of ulcerative colitis in patients who smoke. | Green JT et al. | β | 1998 | β |
| Gender differences in the pharmacology of nicotine addiction. | Benowitz NL et al. | β | 1998 | β |
| Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. | Miller VM et al. | β | 1998 | β |
| Cotinine effects on nicotine metabolism. | Zevin S et al. | β | 1997 | β |
| Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment. | Gourlay SG et al. | β | 1997 | β |
| National incidence of smoking and misclassification among the U.S. married female population. | Ogden MW et al. | β | 1997 | β |
| Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. | Quinn DI et al. | β | 1997 | β |
| Chronopharmacokinetics of nicotine. | Gries JM et al. | β | 1996 | β |
| Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. | Schneider NG et al. | β | 1996 | β |
| Facile Pyridoxal-Catalyzed Racemization of Nornicotine and Related Compounds. | Jacob P | β | 1996 | β |
| Society for Research on Nicotine and Tobacco. | Perkins KA et al. | β | 1996 | β |
| The benefits of stopping smoking and the role of nicotine replacement therapy in older patients. | Gourlay SG et al. | β | 1996 | β |
| Deficient C-oxidation of nicotine. | Benowitz NL et al. | β | 1995 | β |